133 related articles for article (PubMed ID: 29083970)
41. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
[TBL] [Abstract][Full Text] [Related]
42. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
43. Implementation of a medication therapy management collaborative within a pediatric health system.
Sneed G; Kappeler K; Gilmore T; Kuhn C
J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
[TBL] [Abstract][Full Text] [Related]
44. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
45. Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings.
Bishop MA; Chang HY; Kitchen C; Weiner JP; Kharrazi H; Shermock KM
J Manag Care Spec Pharm; 2021 Aug; 27(8):1009-1018. PubMed ID: 34337988
[No Abstract] [Full Text] [Related]
46. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
Wang J; Hong SH; Meng S; Brown LM
Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
[TBL] [Abstract][Full Text] [Related]
47. Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.
Gray C; Cooke CE; Brandt N
Am Health Drug Benefits; 2019 Sep; 12(5):243-251. PubMed ID: 32015791
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
49. Medication therapy management and condition care services in a community-based employer setting.
Johannigman MJ; Leifheit M; Bellman N; Pierce T; Marriott A; Bishop C
Am J Health Syst Pharm; 2010 Aug; 67(16):1362-7. PubMed ID: 20689127
[TBL] [Abstract][Full Text] [Related]
50. A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation.
Gong J; Baker CL; Zou KH; Bruno M; Jumadilova Z; Lawrence D; Wilson B; Ewel C
J Manag Care Spec Pharm; 2016 Dec; 22(12):1417-1425. PubMed ID: 27882838
[TBL] [Abstract][Full Text] [Related]
51. Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs.
Choe HM; Lin AT; Kobernik K; Cohen M; Wesolowicz L; Qureshi N; Leyden T; Share DA; Darland R; Spahlinger DA
J Manag Care Spec Pharm; 2018 Apr; 24(4):373-378. PubMed ID: 29578853
[TBL] [Abstract][Full Text] [Related]
52. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
[TBL] [Abstract][Full Text] [Related]
53. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
[TBL] [Abstract][Full Text] [Related]
54. Understanding the Relationship Between Incentive Design and Participation in U.S. Workplace Wellness Programs.
Batorsky B; Taylor E; Huang C; Liu H; Mattke S
Am J Health Promot; 2016; 30(3):198-203. PubMed ID: 26734957
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
Lounsbery JL; Green CG; Bennett MS; Pedersen CA
J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
[TBL] [Abstract][Full Text] [Related]
56. Variation in Medication Therapy Management Delivery: Implications for Health Care Policy.
Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Hudmon KS; Doucette WR
J Manag Care Spec Pharm; 2018 Sep; 24(9):896-902. PubMed ID: 30156453
[TBL] [Abstract][Full Text] [Related]
57. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
58. Clinical and economic outcomes of medication therapy management services: the Minnesota experience.
Isetts BJ; Schondelmeyer SW; Artz MB; Lenarz LA; Heaton AH; Wadd WB; Brown LM; Cipolle RJ
J Am Pharm Assoc (2003); 2008; 48(2):203-214. PubMed ID: 18359733
[TBL] [Abstract][Full Text] [Related]
59. Conjoint analysis of patient preferences on Medicare medication therapy management.
Hong SH; Liu J; Wang J; Brown L; White-Means S
J Am Pharm Assoc (2003); 2011; 51(3):378-87. PubMed ID: 21555290
[TBL] [Abstract][Full Text] [Related]
60. Optimization of Medication Use at Accountable Care Organizations.
Wilks C; Krisle E; Westrich K; Lunner K; Muhlestein D; Dubois R
J Manag Care Spec Pharm; 2017 Oct; 23(10):1054-1064. PubMed ID: 28944730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
